January 29, 2026 

Bio Stem Technologies Accelerates Into 2026 With Transformative Acquisition, Seven Straight Profitable Quarters, and Entry into Advanced and Acute Wound Care Markets!

BioStem Technologies (OTCQB: BSEM) is emerging as one of the most compelling small-cap MedTech companies as 2026 begins. The company just completed the acquisition of BioTissue Holdings’ surgical and wound care business, instantly expanding its footprint into hospital-based, acute, and surgical wound care. 

With established product lines like Neox® and Clarix®, a nationwide sales force, and key GPO contracts, BioStem is now positioned to capture a $300–$350 million addressable market, spanning chronic and acute wound care, burns, and soft-tissue repair. 

Zacks Small Cap Research has assigned BSEM a $25.50 price target, highlighting confidence in the company’s profitable growth, clinical validation, and expanding market presence.

Coupled with seven consecutive profitable quarters, strong gross margins of 88.5%, and $16 million in cash post-acquisition, BSEM is demonstrating operational excellence rarely seen in small-cap regenerative medicine. 

Backed by clinically validated BioREtain® technology, FDA-level studies, and a potential Nasdaq uplisting in mid-2026, BSEM is gaining traction with both institutional investors and healthcare providers. 

Discover why BSEM is setting the standard for profitable, clinically proven MedTech growth in 2026

Pursuant to an agreement between Guardian Financial Publishing LLC and Sideways Frequency LLC, Guardian Financial Publishing LLC has been hired for a period beginning on 1/29/2025 and ending on 1/29/2025 to publicly disseminate information about (BSEM:US) via digital communications. We have been paid six thousand dollars USD via bank wire transfer. To date we have been paid six thousand dollars USD via bank wire transfer to disseminate information about (BSEM:US) via digital communications. We own zero shares of (BSEM:US).

Update your email preferences or unsubscribe here

© 2026 Stable Financial Publications 

1013 Centre Road Suite 403-D
Wilmington, DE 19805, United StatesTerms of Service